GDNF Gene Therapy for Multiple System Atrophy
Summary
- Eligibility
- for people ages 35-75 (full criteria)
- Location
- at Irvine, California and other locations
- Dates
- study startedcompletion around
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Brain Neurotherapy Bio, Inc.
- Links
- Nurse Navigator Service for Potential Participants
- ID
- NCT04680065
- Phase
- Phase 1 Multiple System Atrophy Research Study
- Study Type
- Interventional
- Participants
- Expecting 9 study participants
- Last Updated